Subtotal: $21,282.00
Subtotal: $21,282.00
Original price was: $2,899.00.$1,999.00Current price is: $1,999.00.
In Stock
Enhertu
HER2-positive breast cancer with metastases, or in the absence of surgical intervention in patients over 18 years of age.
Also indicated for the treatment of adults with metastatic gastric cancer: HER2-positive adenocarcinoma. Enherta is used if the patient has already undergone chemotherapy with trastuzumab (Herceptin) in the first line.
Active ingredient: trastuzumab
Storage temperature 2-8 degrees
Prescription drug
